Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Natco Pharma Ltd Financial Statements & Historical Data

Updated NSE: NATCOPHARMBSE: 524816
Report details
Last Updated:
Author: |Social: XLinkedIn
COMPANY FINANCIAL DATA

Reported figures at a glance

Stored figures, not live quotes. Price record: 28 September 2026, 9:09 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price829₹ per share
Reported P/E13.0Times
Book value per share515₹ per share
Reported ROCE17.4 %%
Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

Stored market and accounting figures

Price record: 28 September 2026, 9:09 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap14,827 Cr.
Current Price829
High / Low1,227/789
Stock P/E13.0
Book Value515
Dividend Yield0.60 %
ROCE17.4 %
ROE17.1 %
Face Value2.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Natco Pharma Ltd 14,827 Cr. 829 1,227/78913.0 5150.60 %17.4 %17.1 % 2.00
Marksans Pharma Ltd 15,027 Cr. 332 351/15529.1 66.70.27 %18.8 %15.2 % 1.00
Concord Biotech Ltd 14,564 Cr. 1,393 1,668/98751.2 1930.54 %17.4 %12.6 % 1.00
Astrazeneca Pharma India Ltd 15,669 Cr. 6,280 9,850/6,26290.3 3490.57 %29.3 %23.3 % 2.00
Alembic Pharmaceuticals Ltd 16,796 Cr. 854 998/63522.5 2891.40 %12.6 %13.4 % 2.00
Industry Average17,774.69 Cr1,258.9655.96211.600.38%26.16%16.59%6.06

All Competitor Stocks of Natco Pharma Ltd

FINANCIALS

Quarterly performance

Compare sales, expenses, operating profit and net profit on one chart, across the same reporting quarters.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 4928981,1401,0317591,0681,3631,3714751,2211,3291,363647739735
Expenses 387559612573490571558567436673758784489612549
Operating Profit 10633952845826849780580439548571579159128186
OPM % 22%38%46%44%35%47%59%59%8%45%43%42%25%17%25%
Other Income 21292029374248641766662100587859
Interest 43445654410313101113
Depreciation 424144444456444647985852465047
Profit before tax 81324500440256478804818164506572614161144186
Tax % 23%15%16%16%17%19%17%17%19%20%16%16%13%-62%34%
Net Profit 62276420369213386668676132406480518151269206
EPS in Rs 3.4115.1123.4720.6011.8821.5737.3237.817.4322.7026.8428.948.4614.9611.53

Last Updated: September 26, 2026, 8:56 pm

FINANCIALS

Annual performance

Compare sales, expenses, operating profit and net profit across financial years. Trailing figures remain in the table.

Sales, expenses & profits

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Earnings per share

₹ per share

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: September 26, 2026, 8:56 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 7398251,0422,0202,1852,0941,9152,0521,9452,7073,9994,4304,0783,485
Expenses 5606157771,3371,2561,3001,3321,4461,6811,7722,2452,2342,6172,433
Operating Profit 1792102666839287955836062649361,7542,1961,4621,052
OPM % 24%25%25%34%42%38%30%30%14%35%44%50%36%30%
Other Income 17012144013010710499105126354272295
Interest 3732231815192213181419243746
Depreciation 304751546681100117143164187235207196
Profit before tax 1291322046248878255695802028621,6742,2911,4911,104
Tax % 24%1%24%22%22%22%19%24%16%17%17%18%8%
Net Profit 981301564856956424584421707151,3881,8831,4181,145
EPS in Rs 6.218.109.0227.8837.7435.2425.3124.189.3139.1877.51105.2679.2063.89
Dividend Payout % 16%12%14%24%22%18%27%22%48%14%12%6%6%

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)32.65%20.00%210.90%43.30%-7.63%-28.66%-3.49%-61.54%320.59%94.13%35.66%-24.69%
Change in YoY Net Profit Growth (%)0.00%-12.65%190.90%-167.60%-50.92%-21.03%25.17%-58.05%382.13%-226.46%-58.46%-60.36%

Natco Pharma Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 12 years from 2014-2015 to 2025-2026.

Growth

Last Updated: September 5, 2025, 11:35 am

FINANCIALS

Balance sheet

Compare reserves and borrowings across the same financial years. Reserves are an accounting balance, not available cash.

Reserves & borrowings

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: September 18, 2026, 5:00 am

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 333535373636363636363636
Reserves 8131,2611,6143,0353,4523,7374,0854,2274,8375,8177,5719,185
Borrowings 312113222173386316268416167371279714
Other Liabilities 2264134464704284984034306176827441,138
Total Liabilities 1,3841,8222,3183,7154,3034,5884,7925,1095,6576,9068,63111,074
Fixed Assets 7107108331,0191,2271,5842,0232,3122,4272,4912,6982,803
CWIP 12921233648063851822313064137225294
Investments 22232761691123043083925394743,127
Other Assets 5438781,1162,1402,2702,3732,2422,3602,7743,7395,2344,850
Total Assets 1,3841,8222,3183,7154,3034,5884,7925,1095,6576,9068,63111,074
FINANCIALS

Cash generation

Compare operating cash and free cash flow across reported periods. Negative values remain visible.

Operating & free cash flow

₹ crore

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 93112346464669417299468491,2121,6971,768
Cash from Investing Activity + -120-176-299-1,116-611-175-1074-465-1,026-1,436-1,987
Cash from Financing Activity + 29154-48651-51-251-18635-363-247-211298
Net Cash Flow 290-1-27-868521-625079
Free Cash Flow -25-4466572258192-1426748551,3001,379
CFO/OP 55%60%69%72%107%90%71%36%110%85%94%148%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow-25.00-44.0066.0057.00225.0081.0092.00-142.00674.00855.001,300.001,379.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

Financial efficiency feed. Source: www.screener.in. The source URL identifies consolidated accounts. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Financial & business efficiency

Compare collection, inventory, payment and working-capital cycles together in days. Returns on capital and equity follow in a separate percentage chart.

Working capital

Days

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Returns on capital & equity

%

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 598592861068810573116115109103
Inventory Days 283331482213389545534570496432357405
Days Payable 172189372160239224244104105153120145
Cash Conversion Cycle 170228202138257410395539507394345362
Working Capital Days 22259771215207295246256198151151
ROCE %18%17%18%39%35%23%14%13%4%18%30%33%
FINANCIALS

Ownership trends

Compare ownership groups across the same reporting dates. Shareholder counts appear separately below.

Shareholding comparison

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Shareholder count

Shareholders

Hover or tap the chart for dated values.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 49.71%49.71%49.71%49.71%49.62%49.62%49.56%49.56%49.48%49.48%49.41%49.41%
FIIs 12.82%13.72%16.14%17.45%17.51%17.94%17.49%15.52%14.09%15.16%17.37%16.99%
DIIs 14.01%11.26%9.69%7.86%6.75%5.59%5.64%5.81%5.87%5.39%5.46%5.63%
Public 23.48%25.32%24.46%24.99%26.13%26.88%27.30%29.12%30.56%29.97%27.74%27.97%
No. of Shareholders 1,63,7532,07,5712,28,4672,51,4853,02,9443,45,3324,05,2224,29,4344,19,6994,24,1674,10,9704,03,166
Mutual fund holdingsReported fund ownership · Expand table

Mutual Fund Holdings Data Table

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
Tata Value Fund 825,000 0.78 68.961,411,4752025-12-15 08:54:25-41.55%
Sundaram Small Cap Fund 603,569 1.54 50.45561,3692025-12-08 07:53:017.52%
Tata Small Cap Fund 549,064 0.43 45.9900,0002025-09-10 00:17:42-38.99%
Baroda BNP Paribas Business Cycle Fund 54,000 0.8 4.5167,5002026-02-23 03:58:30-20%
Sundaram Long Term Micro Cap Tax Advantage Fund - Series III 12,965 1.52 1.08N/AN/AN/A
Sundaram Long Term Micro Cap Tax Advantage Fund - Series VI 6,182 1.51 0.52N/AN/AN/A
Sundaram Long Term Micro Cap Tax Advantage Fund - Series IV 6,109 1.51 0.51N/AN/AN/A
Sundaram Long Term Tax Advantage Fund - Series III 5,676 1.48 0.47N/AN/AN/A
Sundaram Long Term Micro Cap Tax Advantage Fund - Series V 5,139 1.48 0.43N/AN/AN/A
Sundaram Long Term Tax Advantage Fund - Series IV 3,747 1.46 0.31N/AN/AN/A

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

FINANCIALS

Ratios from the alternate data feed

Related measures share a chart and a common unit. Use the dated figures below to examine any change.

Profitability ratios

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Liquidity ratios

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Distributions & retention

%

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Interest coverage

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods

Valuation multiples

Multiple (×)

Compare the lines together. Select a metric below to show or hide it.

Chart loads as you scroll. Values are available in the table.

All reported periods
Supporting financial tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 2.002.002.002.002.00
Basic EPS (Rs.) 105.2677.3439.189.3224.20
Diluted EPS (Rs.) 105.2677.3439.189.3224.16
Cash EPS (Rs.) 118.3687.9948.1717.1330.65
Book Value[Excl.RevalReserv]/Share (Rs.) 424.97326.99267.06233.62225.94
Book Value[Incl.RevalReserv]/Share (Rs.) 424.97326.99267.06233.62225.94
Revenue From Operations / Share (Rs.) 247.46223.40148.33106.56112.44
PBDIT / Share (Rs.) 142.49105.0057.0019.8638.89
PBIT / Share (Rs.) 129.3594.5648.0212.0532.49
PBT / Share (Rs.) 128.0193.4947.2311.0831.76
Net Profit / Share (Rs.) 105.2277.5639.199.3124.24
NP After MI And SOA / Share (Rs.) 105.3377.5639.199.3124.16
PBDIT Margin (%) 57.5747.0038.4218.6334.58
PBIT Margin (%) 52.2742.3332.3711.3028.89
PBT Margin (%) 51.7341.8531.8310.3928.24
Net Profit Margin (%) 42.5134.7126.428.7421.55
NP After MI And SOA Margin (%) 42.5634.7126.428.7421.48
Return on Networth / Equity (%) 24.7823.7114.673.9810.69
Return on Capital Employeed (%) 30.1128.5217.614.9913.89
Return On Assets (%) 21.8420.1012.643.329.20
Total Debt / Equity (X) 0.030.060.030.090.06
Asset Turnover Ratio (%) 0.570.630.500.360.35
Current Ratio (X) 5.594.144.393.524.45
Quick Ratio (X) 4.773.423.302.442.93
Inventory Turnover Ratio (X) 6.040.720.630.690.56
Dividend Payout Ratio (NP) (%) 5.7012.2514.0348.2925.81
Dividend Payout Ratio (CP) (%) 5.0610.8011.4226.2620.40
Earning Retention Ratio (%) 94.3087.7585.9751.7174.19
Cash Earning Retention Ratio (%) 94.9489.2088.5873.7479.60
Interest Coverage Ratio (X) 106.7297.8971.7420.4853.37
Interest Coverage Ratio (Post Tax) (X) 79.8073.3150.3310.6034.26
Enterprise Value (Cr.) 12381.2316442.159905.3114018.6315043.09
EV / Net Operating Revenue (X) 2.804.113.667.217.33
EV / EBITDA (X) 4.858.759.5238.6721.19
MarketCap / Net Operating Revenue (X) 3.224.263.807.117.34
Retention Ratios (%) 94.2987.7485.9651.7074.18
Price / BV (X) 1.882.912.113.243.65
Price / Net Operating Revenue (X) 3.224.263.807.117.34
EarningsYield 0.130.080.060.010.02
Advertisements
Explore Industry-wise Company financial data